Literature DB >> 34184069

Activation of Transient Receptor Potential Vanilloid-3 Channels in Keratinocytes Induces Pruritus in Humans.

Jin Cheol Kim1, Han Bi Kim, Won-Sik Shim, In Suk Kwak, Bo Young Chung, Seok Young Kang, Chun Wook Park, Hye One Kim.   

Abstract

Carvacrol, a natural transient receptor potential vanilloid-3 activator, has been reported to cause pruritus in mice. This study aimed to evaluate the effects of carvacrol and various antipruritic agents in humans. A stimulation test with carvacrol, β-alanine, and histamine was performed. After application of the pruritic solutions, the skin was stimulated with pinpricks. In inhibition test A, Forsythia suspensa extract, containing forsythoside B (a transient receptor potential vanilloid-3 inhibitor), was applied by pricking prior to stimulation with pruritogens. In inhibition test B, olopatadine solution, tacrolimus ointment, and Scutellaria baicalensis root extract were applied, and carvacrol was applied to the same region. Carvacrol induces moderate pruritus in humans. The pruritus was relieved by Forsythia suspensa extract and olopatadine solution after 20 min of application and by tacrolimus ointment and Scutellaria baicalenis extract after 24 h of application. These results suggest that carvacrol is a pruritogen in humans, and that carvacrol-induced pruritus is inhibited by various antipruritic agents.

Entities:  

Keywords:  carvacrol; oregano; pruritus; thymic stromal lymphopoietin; transient receptor potential vanilloid-3; itch

Mesh:

Substances:

Year:  2021        PMID: 34184069      PMCID: PMC9425626          DOI: 10.2340/00015555-3855

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  26 in total

1.  Forsythoside B protects against experimental sepsis by modulating inflammatory factors.

Authors:  Wang-Lin Jiang; Shu-Ping Zhang; Hai-Bo Zhu
Journal:  Phytother Res       Date:  2011-12-06       Impact factor: 5.878

2.  Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.

Authors:  Zhimiao Lin; Quan Chen; Mingyang Lee; Xu Cao; Jie Zhang; Donglai Ma; Long Chen; Xiaoping Hu; Huijun Wang; Xiaowen Wang; Peng Zhang; Xuanzhu Liu; Liping Guan; Yiquan Tang; Haizhen Yang; Ping Tu; Dingfang Bu; Xuejun Zhu; KeWei Wang; Ruoyu Li; Yong Yang
Journal:  Am J Hum Genet       Date:  2012-03-09       Impact factor: 11.025

Review 3.  The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases.

Authors:  Gongxin Wang; KeWei Wang
Journal:  Mol Pharmacol       Date:  2017-04-04       Impact factor: 4.436

4.  TRPV3 is a calcium-permeable temperature-sensitive cation channel.

Authors:  Haoxing Xu; I Scott Ramsey; Suhas A Kotecha; Magdalene M Moran; Jayhong A Chong; Deborah Lawson; Pei Ge; Jeremiah Lilly; Inmaculada Silos-Santiago; Yu Xie; Peter S DiStefano; Rory Curtis; David E Clapham
Journal:  Nature       Date:  2002-06-23       Impact factor: 49.962

5.  Pharmacological Inhibition of the Temperature-Sensitive and Ca2+-Permeable Transient Receptor Potential Vanilloid TRPV3 Channel by Natural Forsythoside B Attenuates Pruritus and Cytotoxicity of Keratinocytes.

Authors:  Heng Zhang; Xiaoying Sun; Hang Qi; Qingxia Ma; Qiqi Zhou; Wei Wang; KeWei Wang
Journal:  J Pharmacol Exp Ther       Date:  2018-10-30       Impact factor: 4.030

6.  Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes.

Authors:  Attila Gábor Szöllősi; Nikolett Vasas; Ágnes Angyal; Kornél Kistamás; Péter Pál Nánási; Johanna Mihály; Gabriella Béke; Erika Herczeg-Lisztes; Andrea Szegedi; Naoki Kawada; Takashi Yanagida; Takahiro Mori; Lajos Kemény; Tamás Bíró
Journal:  J Invest Dermatol       Date:  2017-09-28       Impact factor: 8.551

7.  Baicalein as a Potential Inhibitor against BACE1 and AChE: Mechanistic Comprehension through In Vitro and Computational Approaches.

Authors:  Jin Han; Yeongseon Ji; Kumju Youn; GyuTae Lim; Jinhyuk Lee; Dong Hyun Kim; Mira Jun
Journal:  Nutrients       Date:  2019-11-07       Impact factor: 5.717

8.  Olmsted syndrome: exploration of the immunological phenotype.

Authors:  Dina Danso-Abeam; Jianguo Zhang; James Dooley; Kim A Staats; Lien Van Eyck; Thomas Van Brussel; Shari Zaman; Esther Hauben; Marc Van de Velde; Marie-Anne Morren; Marleen Renard; Christel Van Geet; Heidi Schaballie; Diether Lambrechts; Jinsheng Tao; Dean Franckaert; Stephanie Humblet-Baron; Isabelle Meyts; Adrian Liston
Journal:  Orphanet J Rare Dis       Date:  2013-05-21       Impact factor: 4.123

9.  TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury.

Authors:  Wenliang Chen; Baofeng Xu; Aijiao Xiao; Ling Liu; Xiaoyan Fang; Rui Liu; Ekaterina Turlova; Andrew Barszczyk; Xiao Zhong; Christopher L F Sun; Luiz R G Britto; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Mol Brain       Date:  2015-02-19       Impact factor: 4.041

10.  Itching Caused by TRPV3 (Transient Receptor Potential Vanilloid-3) Activator Application to Skin of Burn Patients.

Authors:  Hye One Kim; Kim Jin Cheol; Kong Yu Gyeong; Kwak In Suk
Journal:  Medicina (Kaunas)       Date:  2020-10-25       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.